Answers are grounded in this paper and cite their sources.
BackgroundOral squamous cell carcinoma (OSCC) is the most common type of oral cancer and remains a major global health challenge due to delayed diagnosis and poor prognosis.Salivary inflammatory cytokines have emerged as promising non-invasive biomarkers for the early detection of OSCC.This study aimed to evaluate and compare salivary Interleukin-1 beta (IL-1β) and Interleukin-6 (IL-6) levels among healthy individuals and patients with histopathologically confirmed OSCC. MethodologyThis comparative case-control study included 126 participants, comprising 63 healthy controls and 63 patients with OSCC.Demographic characteristics and habit history, including tobacco and alcohol use, were recorded.Unstimulated whole saliva samples were collected using the passive drool technique, and salivary IL-1β and IL-6 concentrations were quantified using enzyme-linked immunosorbent assay (ELISA).Statistical analysis was performed using statistical software, and p < 0.05 was considered statistically significant. ResultsOSCC was more prevalent among men and individuals with tobacco-related habits, particularly smokeless tobacco use.The buccal mucosa was the most commonly affected anatomical site.Salivary IL-1β and IL-6 levels were significantly higher in patients with OSCC than in healthy controls (IL-1β: 69.26 ± 88.40 vs. 25.11± 59.50 pg/mL, p = 0.001; IL-6: 54.71 ± 65.90 vs. 3.36 ± 1.35 pg/mL, p < 0.001). ConclusionSalivary IL-1β and IL-6 concentrations were significantly elevated in patients with OSCC compared with healthy controls, indicating an association between these inflammatory cytokines and OSCC.Future multicenter prospective studies incorporating diagnostic accuracy assessments are warranted to establish their potential clinical utility.
No takes yet. Share an insight, caveat, or question.
Suragimath et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: